AI Multi-Horizon Analysis
No intraday data supplied; daily close at 884.74 after 5.3% decline leaves no actionable minutes-level edge.
Daily price below all major EMAs and SMAs (926-979 zone), negative MACD, RSI near 39, and 5.3% session loss amid broad market decline point to bearish pressure over hours to days despite strong longer-term financial trajectory.
Four-period financials show accelerating revenue (from 13.643B to 133.188B), expanding FCF (3.022B to 58.963B), rising cash and equity, and falling debt/equity from 0.19 to 0.03. Monthly indicators remain constructive above rising EMAs with positive MACD despite recent margin moderation.
MU exhibits strong long-term fundamental acceleration in revenue, FCF, cash, and equity with sharply declining debt/equity, yet daily technicals show bearish momentum with price below key EMAs and negative MACD. Insider selling is heavy in dollar terms. Short-term risk-off session pressure conflicts with monthly uptrend, producing a neutral stance pending clearer trigger.
Detailed AI Fundamental Analysis
Business Snapshot
- Micron Technology, Inc. (NASDAQ: MU) is a US-listed common stock, linked to SEC CIK 723125. The supplied data do not include a detailed business description or sector classification.
- The daily digest window is the next regular US trading session, with the last regular close at $884.74 on 2026-10-30. Fundamentals are a backdrop for that one-session call: the next report is estimated for 2026-12-16, outside the window, and is not announced; the supplied estimate is $37.93 EPS from 9 analysts.
- Context is risk-off in the supplied session data: SPY fell 1.77% and QQQ fell 3.47%; MU fell 5.30%.
Financial Trends
- Revenue rose sharply across the four reported periods: $13.643B (2025-11-27), $23.860B (2026-02-26), $41.456B (2026-05-28), and $133.188B (2026-09-03). Sequential increases were $10.217B, $17.596B, and $91.732B; latest revenue was $119.545B above the earliest period, about 9.8x its level. The latest step-up is especially large, though the payload does not clarify whether every value is a standalone quarter or a different reporting-period basis.
- Margins improved substantially versus four periods ago, but eased in the latest period versus the prior one. Gross margin went from 56.04% to 74.41%, 84.56%, then 80.72% (latest vs prior: -3.84 percentage points). Operating margin rose from 44.98% to 67.62%, 80.37%, then 74.59% (latest vs prior: -5.78 points). Net margin rose from 38.41% to 57.77%, 68.13%, then 63.80% (latest vs prior: -4.33 points). The broad trajectory is a strong recovery from the earliest period, with a recent pullback from the prior period’s peak.
- FCF increased at each reported step: $3.022B, $8.538B, $26.100B, and $58.963B. Latest FCF was $32.863B higher than the prior period and $55.941B higher than four periods ago. Operating cash flow also rose from $8.411B to $89.675B, while capex increased from $5.389B to $30.712B—investment spending is growing, but reported FCF has risen alongside it.
- Balance-sheet measures strengthened over the four observations. Cash increased from $9.731B to $38.364B; current ratio improved from 2.46 to 3.31, after reaching 3.42 in the prior period; working capital rose from $17.605B to $63.588B. Debt/equity declined from 0.19 to 0.03. Total assets increased from $85.971B to $195.888B, while total liabilities rose from $27.165B to $57.510B.
Financial Health
- The latest reported snapshot indicates strong liquidity and a low debt/equity ratio, supported by $38.364B of cash, a 3.31 current ratio, and $58.963B of reported FCF. These figures are consistent with the improving balance-sheet and cash-generation trajectory.
- The caution is not a collapse in the longer trend, but a recent margin retreat from the prior period’s highs: gross, operating, and net margins all declined in the latest observation. Inventory also rose from $8.205B four periods ago to $10.372B; the supplied data do not establish whether that increase is a concern.
- Interpret the financial figures cautiously: the supplied tables label all four observations as quarterly, but the unusually large latest jumps—and the latest 10-K label—make period comparability unclear. No additional detail is provided to reconcile that presentation. No valuation multiples or further operating-segment data are supplied.
Insider Activity
- The summary for 2026-08-03 to 2026-11-01 is negative in dollar terms: $0 in reported buys versus $394.5M in reported sells across 49 buys and 85 sells, for a net -$394.5M and a sentiment score of -10 (Neutral).
- Disclosed examples include a reported $25.6M sale by Scott J. Deboer at $900.00 on 2026-10-16, and sizeable reported sales by Sanjay Mehrotra at $989.04 on 2026-10-13. Numerous entries list zero-dollar buys alongside sales; those entries should not be treated as open-market purchases at the listed $0 price. The data do not establish the motivation or whether these were scheduled transactions.
- Overall, the dollar-weighted activity is a cautionary sentiment signal, but it is not sufficient by itself to determine near-term direction.
Multi-Timeframe Technical Context
- Ultra-short (minutes): No intraday timeframe data are supplied, so a minutes-level setup cannot be assessed.
- Short (hours to days; primary digest horizon): The last regular session closed at $884.74, down 5.30%, while the broad-market comparators also declined. On the daily indicators, price is below EMA 12 ($926.04), EMA 26 ($950.99), EMA 50 ($958.79), SMA 20 ($950.61), and SMA 50 ($978.71), a weak near-term configuration. MACD (-24.96) is below its signal (-23.88). RSI 14 is 39.12 and RSI 21 is 34.19: weak, but not below 30. Price is above the lower Bollinger Band ($811.85) and below the middle band ($950.61). Daily ATR is $51.00, indicating material price movement relative to the close. Volume was 30.9M, above the 20-day average of 26.1M.
- Longer horizon (weeks to months): The monthly view remains strong in its broad historical trend: the 81-bar close rose 1,561.37% over the displayed series, and price remains above monthly EMA 12 ($720.58), EMA 26 ($491.01), EMA 50 ($328.72), and SMA 20 ($453.09). Monthly RSI 14 is 69.7, near the conventional overbought area, while monthly MACD (229.57) is above its signal (166.50). This long-horizon strength contrasts with the weaker daily setup.
- The supplied daily 200-bar series shows a 156.21% gain, but the quoted close is well below its recorded high of $1,255.00. The data provide no intraday bars to refine immediate support or a reversal signal.
Bull / Bear Cases
- Short-term bull case: RSI readings show weakness but are not below 30, and the close remains above the daily lower Bollinger Band ($811.85). A stabilization or recovery above the daily EMA 12 ($926.04) would improve the near-term picture; above the $950.61–$978.71 moving-average area would offer firmer confirmation. This is conditional, not an established reversal.
- Short-term bear case: MU fell 5.30% in the last session amid broad-market declines; daily MACD is negative and below its signal, and price sits below the short- and medium-term moving averages. A break below the lower Bollinger Band level of $811.85 would weaken the setup further. Elevated reported volume and negative dollar-weighted insider activity add caution, though neither determines the next session’s move.
- Long-term bull case: The monthly trend remains above its major supplied averages, with monthly MACD positive and above its signal. Across the four financial observations, revenue, FCF, cash, and working capital increased substantially, while debt/equity declined.
- Long-term bear case: The monthly RSI is near 70, the share price is materially below the displayed $1,255.00 high, and the latest daily trend is weak. The recent pullback in all three reported margins from the prior observation and the uncertainty over comparability of the financial periods temper conclusions about continued acceleration.
Key Levels & Triggers
- Near-term support reference: $811.85, the daily lower Bollinger Band. A sustained move below this level would be a negative technical development; it is an indicator level, not guaranteed support.
- First recovery reference: $926.04, daily EMA 12. Reclaiming it would ease some immediate pressure, but price would still need to contend with the daily EMA 26 at $950.99, SMA 20 at $950.61, EMA 50 at $958.79, and SMA 50 at $978.71.
- Longer-term trend reference: $746.83, the daily SMA 200. It is below the current close but does not replace the weaker short-term signals.
- Trading-room read for the next session: Wait / no trade is the more measured stance on the supplied evidence: daily momentum is bearish, but the monthly trend remains strong and the close is above the daily lower Bollinger Band. No intraday data are provided to confirm an entry trigger.